Organogenesis Holdings Inc (ORGO) — Cash Flow-to-Debt Ratio
Organogenesis Holdings Inc (ORGO) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of $3.08 Million could theoretically repay 0% of its total liabilities ($123.85 Million) in one year. See financial agility of Organogenesis Holdings Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Organogenesis Holdings Inc Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Organogenesis Holdings Inc across 11 annual periods. For the full cash flow conversion analysis, see Organogenesis Holdings Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Organogenesis Holdings Inc (2001–2024)
Year-by-year debt coverage analysis for Organogenesis Holdings Inc. Check Organogenesis Holdings Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | $14.21 Million | $112.57 Million | ▼ -26.0% |
| 2023 | 0.17x | $30.92 Million | $181.36 Million | ▲ +26.0% |
| 2022 | 0.14x | $24.86 Million | $183.69 Million | ▼ -55.9% |
| 2021 | 0.31x | $61.98 Million | $201.92 Million | ▲ +733.4% |
| 2020 | 0.04x | $5.47 Million | $148.41 Million | ▲ +118.1% |
| 2019 | -0.20x | $-33.53 Million | $165.10 Million | ▲ +61.0% |
| 2018 | -0.52x | $-60.74 Million | $116.64 Million | ▼ -1212.0% |
| 2017 | -0.04x | $-586.60K | $14.78 Million | ▲ +20.0% |
| 2016 | -0.05x | $-562.23K | $11.33 Million | ▲ +99.8% |
| 2015 | -24.48x | $-10.19 Million | $416.43K | ▼ -8145.9% |
| 2001 | -0.30x | $-1.40 Million | $4.70 Million | — |